Evaluating a new international risk-prediction tool in IgA nephropathy
…, R Katafuchi, L Er, G Espino-Hernandez… - JAMA internal …, 2019 - jamanetwork.com
Importance Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the
world, there is no validated tool to predict disease progression. This limits patient-specific …
world, there is no validated tool to predict disease progression. This limits patient-specific …
[HTML][HTML] The MEST score provides earlier risk prediction in lgA nephropathy
SJ Barbour, G Espino-Hernandez, HN Reich… - Kidney international, 2016 - Elsevier
The Oxford Classification of IgA nephropathy (IgAN) includes the following four histologic
components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and …
components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and …
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: a provincial, population-based …
MJ Walker, O Meggetto, J Gao, G Espino-Hernández… - Preventive …, 2021 - Elsevier
It is essential to quantify the impacts of the COVID-19 pandemic on cancer screening, including
for vulnerable sub-populations, to inform the development of evidence-based, targeted …
for vulnerable sub-populations, to inform the development of evidence-based, targeted …
Delivery of cancer care in Ontario, Canada, during the first year of the COVID-19 pandemic
…, S Habbous, NN Rad, G Espino-Hernández… - JAMA Network …, 2022 - jamanetwork.com
Importance The COVID-19 pandemic has impacted cancer systems worldwide. Quantifying
the changes is critical to informing the delivery of care while the pandemic continues, as well …
the changes is critical to informing the delivery of care while the pandemic continues, as well …
Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
…, M Beaulieu, G Espino-Hernandez… - Nephrology Dialysis …, 2013 - academic.oup.com
Background High fibroblast growth factor-23 (FGF-23) levels are associated with adverse
outcomes. We studied the responsiveness of FGF-23 and mineral metabolism to altered …
outcomes. We studied the responsiveness of FGF-23 and mineral metabolism to altered …
[HTML][HTML] Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis
SJ Barbour, DC Cattran, G Espino-Hernandez… - Kidney international, 2015 - Elsevier
The majority of our insight about glomerulonephritis (GN) is from observational research.
Because proteinuria is an important element of outcome in GN, the validity of observational …
Because proteinuria is an important element of outcome in GN, the validity of observational …
Prescription patterns in dialysis patients: differences between hemodialysis and peritoneal dialysis patients and opportunities for deprescription
…, C Lo, A Pai, G Espino-Hernandez… - Canadian journal of …, 2020 - journals.sagepub.com
Background: Patients treated with maintenance dialysis are at high risk of polypharmacy given
their many comorbidities as well as complications from their disease state and treatment. …
their many comorbidities as well as complications from their disease state and treatment. …
[HTML][HTML] Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program …
…, MJ Walker, G Espino-Hernandez… - … Open Access Journal, 2021 - cmajopen.ca
Background: Breast cancer screening in Ontario, Canada, was deferred during the first wave
of the COVID-19 pandemic, and a prioritization framework to resume services according to …
of the COVID-19 pandemic, and a prioritization framework to resume services according to …
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice
S Barbour, C Lo, G Espino-Hernandez… - Nephrology Dialysis …, 2018 - academic.oup.com
Background Immunosuppression (IS) is the main treatment for most types of glomerulonephritis
(GN). Quantifying the cost of IS is necessary to ensure equitable access to therapies and …
(GN). Quantifying the cost of IS is necessary to ensure equitable access to therapies and …
The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists
…, M Beaulieu, J Gill, G Espino-Hernandez… - Clinical Kidney …, 2014 - academic.oup.com
Background The lack of glomerulonephritis (GN) guidelines has historically contributed to
substantial variability in the treatment of GN. We hypothesize that there are barriers to GN …
substantial variability in the treatment of GN. We hypothesize that there are barriers to GN …